Duopharma said in a statement that financial performance had improved in the topline due to higher sales to the consumer healthcare sector during the reported quarter.
PETALING JAYA: Duopharma Biotech Bhd
’s net profit rose about 30% year-on-year (y-o-y) to RM17.61mil in its first quarter ended March 31,2021.
Its bottom line rose was in tandem with the increase in revenue by almost 5% y-o-y to RM166.45mil.
Already a subscriber? Log in.
Limited time offer:
Just RM5 per month.
Cancel anytime. No ads. Auto-renewal. Unlimited access to the web and app. Personalised features. Members rewards.
Follow us on our official WhatsApp channel for breaking news alerts and key updates!
